TROY, Mich., April 11, 2016 -- SIPP International Industries, Inc. (OTC Markets:SIPN) announced today that it will enact sweeping administrative changes, including the relocation of the company's key personnel from Las Vegas, Nevada to Troy, Michigan. The changes coincide with the long awaited launch of SIPP's new and revolutionary, life saving product, “PYROCHILL”. The reported measures are the company's effort to consolidate company management, product bottling and manufacturing facilities, as well as establishing a more streamlined product distribution center. The company is also hoping to capitalize on the State of Michigan corporate incentive programs.
While the rest of the company begins to pack their bags, the executive offices however, will remain in Pueblo, Colorado until the board of directors convenes to discuss the matter further. The board of directors firmly believes that the changes will allow for greater control of the order taking and fulfillment process of anticipated “PYROCHILL” orders. Administratively, the company also elected to file the necessary documents with the OTC Markets which will elevate the company back up to the “CURRENT” tier level.
“The launch of PYROCHILL will remain on schedule and a detailed report of the launch and marketing efforts will be made available within the next twenty four to forty eight hours,” states, Christopher Fascenelli, SIPP's Director of Marketing. “We are excited about the changes that are taking place, and it is our number one priority of the company to become more open and transparent with its current and future shareholders. A more efficient and accessible operation will greatly benefit everyone associated with SIPP International Industries, Inc., directly or indirectly.
Safe Harbor Statement
This site and the press releases or posts on it contain forward-looking statements, particularly as related to, among other things, the business plans of the Company, statements relating to goals, plans and projections regarding the Company’s financial position and business strategy. The words or phrases “would be,” “will allow,” “intends to,” “may result,” “are expected to,” “will continue,” “anticipates,” “expects,” “estimate,” “project,” “indicate,” “could,” “potentially,” “should,” “believe,” “think”, “considers” or similar expressions are intended to identify “forward-looking statements.” These forward-looking statements fall within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934 and are subject to the safe harbor created by these sections. Actual results could differ materially from those projected in the forward-looking statements as a result of a number of risks and uncertainties. Such forward-looking statements are based on current expectations, involve known and unknown risks, a reliance on third parties for information, transactions or orders that may be canceled, and other factors that may cause our actual results, performance or achievements, or developments in our industry, to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from anticipated results include risks and uncertainties related to the fluctuation of global economic conditions, the performance of management and our employees, our ability to obtain financing, competition, general economic conditions and other factors that are detailed in our periodic reports and on documents we file from time to time with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company cautions readers not to place undue reliance on such statements. The Company does not undertake, and the Company specifically disclaims any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement. Actual results may differ materially from the Company’s expectations and estimates.
Information contact: Louis Johnson IR/Administrator (855)411-8773 (248)224-3120


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Washington Post Publisher Will Lewis Steps Down After Layoffs
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 



